Christopher Visioli
Director of Finance/CFO chez POPULATION HEALTH INVESTMENT CO., INC.
Profil
M. Christopher Visioli est directeur financier chez Population Health Investment Co., Inc. et directeur financier et comptable chez The Medicines Co. M. Visioli était auparavant employé par The Medicines Co. en tant que premier vice-président chargé de la stratégie financière. Il a obtenu son diplôme de premier cycle à l'université Cornell et un MBA à la Columbia Business School.
Postes actifs de Christopher Visioli
| Sociétés | Poste | Début |
|---|---|---|
| POPULATION HEALTH INVESTMENT CO., INC. | Director of Finance/CFO | 11/09/2020 |
Anciens postes connus de Christopher Visioli
| Sociétés | Poste | Fin |
|---|---|---|
| THE MEDICINES COMPANY | Director of Finance/CFO | 01/05/2020 |
Formation de Christopher Visioli
| Cornell University | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Population Health Investment Co., Inc.
 Population Health Investment Co., Inc. Financial ConglomeratesFinance Population Health Investment Co., Inc. operates as a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase and reorganization or similar business combination with one or more businesses. It intends to focus on companies in the healthcare industry such as the therapeutics sector. The company was founded by Clive A. Meanwell and Ian C. Read on September 11, 2020 and is headquartered in New York, NY. | Finance |
